A carregar...
Biphasic human insulin 30 thrice daily, is it reasonable?
OBJECTIVE: To evaluate the efficacy and safety of thrice daily Biphasic Human Insulin 30 (BHI 30) versus the traditional twice-daily regimen in type 2 diabetes mellitus (T2DM) patients. It’s a cross over single clinical study. Twenty-two diabetic patients who were already using BHI 30 in twice or th...
Na minha lista:
| Publicado no: | BMC Res Notes |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7247174/ https://ncbi.nlm.nih.gov/pubmed/32448382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-020-05090-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|